Blood Culture Tests Market - Top Companies and Manufacturers

  • Report ID: 4851
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Blood Culture Tests Landscape

    • Becton, Dickinson and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche AG
    • Cepheid
    • Scenker Biological Technology Co., Ltd
    • Bio-Rad Laboratories, Inc.
    • TERUMO BCT, INC.
    • bioMérieux SA
    • Accelerate Diagnostics, Inc.
    • DiaSorin S.p.A.

Browse Key Market Insights with Data Illustration:

In the News

  • In 2023, Roche announced that it has strengthened its research and innovation efforts by expanding its partnership with Janssen Biotech to develop companion diagnostics for targeted therapies. With the latest agreement expansion, Roche and Janssen intend to increase opportunities to collaborate on precision medicine projects including a variety of companion diagnostic technologies such as immunohistochemistry, digital pathology, next generation sequencing, polymerase chain reaction and immunoassays.
  • In August 2023, Thermo Fisher Scientific announced that it had acquired CorEvitas, LLC from Audax Private Equity for USD 912.5 million. CorEvitas is a leading provider of regulatoryally validated, realworld evidence for approved medical treatments and therapy.

Author Credits:  Radhika Pawar


  • Report ID: 4851
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood culture tests is evaluated at USD 7.27 billion.

Blood Culture Tests Market size was valued at USD 6.64 billion in 2024 and is projected to exceed USD 28.31 billion by the end of 2037, expanding at over 11.8% CAGR during the forecast period i.e., between 2025-2037. The growing cases of HAI and growth strategies by market players will drive the market growth.

Asia Pacific industry is estimated to hold largest revenue share of 33% by 2037, as blood cultures are becoming a more important tool to help identify the best course of therapy and promote effective management.

The major players in the market are of F. Hoffmann-La Roche AG, Cepheid, Scenker Biological Technology Co., Ltd, Bio-Rad Laboratories, Inc., TERUMO BCT, INC., bioMérieux SA, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample